MedPath

Pharmaceutical Companies

Laurus Generics Inc.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Established
-
Employees
-
Market Cap
$2.9B
Website
-
ImmunityBio logo

ImmunityBio

πŸ‡ΊπŸ‡ΈUnited States
Ownership
Public, Subsidiary
Established
2014-01-01
Employees
628
Market Cap
$2.9B
Website
http://www.immunitybio.com
ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the...

RHYTHM PHARMACEUTICALS, INC

πŸ‡ΈπŸ‡ͺSweden
Ownership
-
Established
-
Employees
-
Market Cap
$2.8B
Website
-

Piramal Pharma Inc.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Established
-
Employees
-
Market Cap
$2.8B
Website
-
Morphic Therapeutic, Inc. logo

Morphic Therapeutic, Inc.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
Public, Subsidiary
Established
2015-01-01
Employees
101
Market Cap
$2.8B
Website
http://www.morphictx.com
MorphoSys logo

MorphoSys

πŸ‡©πŸ‡ͺGermany
Ownership
Public, Subsidiary
Established
1992-01-01
Employees
524
Market Cap
$2.8B
Website
http://www.morphosys.de
MorphoSys AG is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapies for people living with cancer and autoimmune diseases. MorphoSys is advancing its own pipeline of new drug candidates...

Geron

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Established
-
Employees
141
Market Cap
$2.8B
Website
-

KOBAYASHI PHARMACEUTICALS

πŸ‡―πŸ‡΅Japan
Ownership
-
Established
-
Employees
-
Market Cap
$2.7B
Website
-
PTC Therapeutics logo

PTC Therapeutics

πŸ‡ΊπŸ‡ΈUnited States
Ownership
Public
Established
1998-01-01
Employees
1K
Market Cap
$2.7B
Website
http://www.ptcbio.com
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded...
Apogee Therapeutics logo

Apogee Therapeutics

πŸ‡ΊπŸ‡ΈUnited States
Ownership
Public
Established
2022-01-01
Employees
91
Market Cap
$2.6B
Website
http://www.apogeetherapeutics.com
Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded...
Β© Copyright 2025. All Rights Reserved by MedPath